Current Lung Asbestosis Approach for Diagnosis, Not Just Histopathology: A Literature Review

Authors

  • Nori Purnama Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Riau, Arifin Achmad General Hospital, Pekanbaru
  • Indi Esha Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Riau, Arifin Achmad General Hospital, Pekanbaru https://orcid.org/0009-0007-9992-1852
  • Adrianison Adrianison Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Riau, Arifin Achmad General Hospital, Pekanbaru
  • Arya Marganda Simanjuntak Faculty of Medicine, Universitas Riau, Pekanbaru https://orcid.org/0000-0001-8680-7865

DOI:

https://doi.org/10.36497/jri.v45i1.678

Keywords:

asbestosis, asbestos body, diagnosis

Abstract

Asbestosis is characterized by diffuse interstitial fibrosis in the lungs, which is caused by breathing asbestos fibers from the crystalline or amphibole groups. The diagnosis of asbestosis, a form of pneumoconiosis, is one of the seven steps in identifying an occupational lung disease. Because there is no known cure for this condition, early detection, prevention, and education of workers and anybody in their proximity who has a risk of asbestos fiber exposure is critical. Clinical symptoms of asbestosis include weight loss, decreased appetite, and dyspnea during exertion. Clubbing fingers, cyanosis, and tachypnea are all symptoms of severe asbestosis. Bronchoalveolar lavage (BAL), histology, CT scans, HRCT, and respirometry can all help with the diagnosis. The "shaggy heart border sign" on a chest X-ray, along with the asbestos body observed in the BAL, is a reliable indicator of asbestosis. Because of the dismal prognosis and lifelong consequences, prevention is essential.

Downloads

Download data is not yet available.

References

1. American Lung Association. Learn about asbestosis [Internet]. 2024 [cited 2024 Dec 14]. Available from: https://www.lung.org/lung-health-diseases/lung-disease-lookup/asbestosis/learn-about-asbestosis

2. Kishimoto T, Morinaga K, Kira S. The prevalence of pleural plaques and/or pulmonary changes among construction workers in Okayama, Japan. Am J Ind Med. 2000;37(3):291–5.

3. Ou Z, Li X, Cui J, Zhu S, Feng K, Ma J, et al. Global, regional, and national burden of asbestosis from 1990 to 2019 and the implications for prevention and control. Science of the Total Environment. 2023;904:166346.

4. Yang M, Wang D, Gan S, Fan L, Cheng M, Yu L, et al. Increasing incidence of asbestosis worldwide, 1990-2017: Results from the Global Burden of Disease study 2017. Thorax. 2020;75(9):798–800.

5. World Health Organization. Elimination of asbestos-related diseases. Geneva; 2018.

6. Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global asbestos disaster. Int J Environ Res Public Health. 2018;15(5):1000.

7. Walters GI, Robertson AS, Bhomra PS, Burge PS. Asbestosis is prevalent in a variety of construction industry trades. NPJ Prim Care Respir Med. 2018;28(1):11.

8. Marsili D, Terracini B, Santana VS, Ramos-Bonilla JP, Pasetto R, Mazzeo A, et al. Prevention of asbestos-related disease in countries currently using asbestos. Int J Environ Res Public Health. 2016;13(5):494.

9. Ferrante P. Asbestosis and silicosis hospitalizations in Italy (2001-2015): Results from the National Hospital Discharge Registry. Eur J Public Health. 2019;29(5):876–82.

10. Gaudino G, Xue J, Yang H. How asbestos and other fibers cause mesothelioma. Transl Lung Cancer Res. 2020;9(Suppl 1):S39–46.

11. Suraya A, Nowak D, Sulistomo AW, Icksan AG, Syahruddin E, Berger U, et al. Asbestos-related lung cancer: A hospital-based case-control study in Indonesia. Int J Environ Res Public Health. 2020;17(2):591.

12. Ikhsan M, Yunus F, Susanto AD. Bunga rampai penyakit paru kerja dan lingkungan. 1st ed. Jakarta: Balai Penerbit; 2009.

13. Bhandari J, Thada PK, Sedhai YR. Asbestosis. Treasure Island (FL): StatPearls; 2022.

14. Ospina D, Villegas VE, Rodríguez-Leguizamón G, Rondón-Lagos M. Analyzing biological and molecular characteristics and genomic damage induced by exposure to asbestos. Cancer Manag Res. 2019;11:4997–5012.

15. Grippi MA, Elias JA, Fisherman JA, Kotloff RM, Pack AI, Senior RM. Fishman’s pulmonary disease and disorders. 5th ed. McGraw-Hill Education. McGraw-Hill Education; 2015. 361–78 p.

16. Perhimpunan Dokter Paru Indonesia. Buku ajar pulmonologi dan kedokteran respirasi. Rasmin M, Jusuf A, Amin M, Taufik, Nawas MA, Ngurah Rai IB, et al., editors. Vol. 2. Jakarta: UI Publishing; 2018. 157–164 p.

17. Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: Recommendations. Scand J Work Environ Health. 2015;41(1):5–15.

18. Becklake MR, Bagatin E, Neder JA. Asbestos-related diseases of the lungs and pleura: Uses, trends and management over the last century. International Journal of Tuberculosis and Lung Disease. 2007;11(4):356–69.

19. Baur X. Asbestos-related disorders in germany: Background, politics, incidence, diagnostics and compensation. Int J Environ Res Public Health. 2018;15(1):143.

20. Bledsoe JR, Christiani DC, Kradin RL. Smoking-associated fibrosis and pulmonary asbestosis. International Journal of COPD. 2014;10:31–7.

21. Sartorelli P, Indini S, Bianchi F, D’alessandro M, Bergantini L, Cameli P, et al. Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers. Medicina del Lavoro. 2020;111(5):379–87.

Downloads

Published

2025-01-31

Issue

Section

Article Review

Similar Articles

1-10 of 75

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)